Predictors for heparin resistance in patients undergoing coronary artery bypass grafting

Ranucci, M.; Isgrο, G.; Cazzaniga, A.; Soro, G.; Menicanti, L.; Frigiola, A.
November 1999
Perfusion;1999, Vol. 14 Issue 6, p437
Academic Journal
Heparin resistance (HR) is a common event in cardiac operations. At present, no clear recognition of the risk factors for HR has been reached. The aim of this study was to determine a predictive model for HR, based on the preoperative patient's profile. Two hundred consecutive patients scheduled for elective coronary artery bypass operations were enrolled in a prospective trial. Demographics, type of preoperative anticoagulation therapy and preoperative coagulation profile were collected and statistically analysed with respect to the evidence of a HR. Heparin resistance was defined as at least one activated clotting time < 400 s after heparinization and/or the need for purified antithrombin III (AT-III) administration. With a multivariate analysis we could identify five predictors for HR: AT-III ≤ 60%; preoperative subcutaneous heparin therapy; intravenous heparin therapy; platelet count ≥ 300 000 cells/mm[sup 3]; age ≥ 65 years. We conclude that HR is a predictable event. In the presence of all the risk factors, the likelihood of HR is 99%; in the absence of all of them, it is 10%. Predicting HR allows us to apply many possible therapeutic strategies.


Related Articles

  • Different patterns of heparin resistance: therapeutic implications. Ranucci, M; Isgrò, G; Cazzaniga, A; Ditta, A; Boncilli, A; Cotza, M; Carboni, G; Brozzi, S // Perfusion;May2002, Vol. 17 Issue 3, p199 

    Heparin resistance (HR) during cardiac operations is a common feature. Its aetiology often recognizes a decrease in circulating antithrombin III (AT III) due to a preoperative heparin treatment. Nevertheless, some papers highlighted the existence of HR in patients with normal values of AT III....

  • Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery. Belboul, A.; Al-Khaja, N. // Perfusion;1997, Vol. 12 Issue 6, p385 

    To evaluate whether the effect of heparin coating the extracorporeal circuit resulted in differences in patient outcome and haemostatic alteration, 24 patients undergoing elective, isolated coronary artery bypass were randomized prospectively to cardiopulmonary bypass (CPB) with heparin-coated...

  • Heparin-bonded circuits without a cardiotomy: a description of a minimally invasive technique of cardiopulmonary bypass. Lilly, Kevin J; O'Gara, Paul J; Treanor, Patrick R; Crowley, Richard; Reardon, Deborah L; Shapira, Oz M; Khuri, Shukri F; Aldea, Gabriel S; Shemin, Richard J // Perfusion;Mar2002, Vol. 17 Issue 2, p95 

    The deleterious effects of cardiotomy suction have been well recognized and well documented for some time. The use of cardiotomy suction results in the exposure of blood to the defoaming sock, aspiration of stagnant pericardial blood into the systemic circulation, and the entrainment of both...

  • Neurone-specific enolase and Sangtec 100 assays during cardiac surgery: part I - the effects of heparin, protamine and propofol. Gao, F.; Harris, D.; Sapsed-Bryne, S.; Sharp, S. // Perfusion;1997, Vol. 12 Issue 3, p163 

    Neurone-specific enolase (NSE) and Sangtec 100 (S-100) (Sangtec Medical, Sweden) assays are designed for clotted samples, but when studying cerebral damage following cardiac surgery, perioperative samples will contain heparin and/or protamine. The lipid emulsion propofol is also frequently used...

  • Haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces. Wendel, H.P.; Scheule, A.M.; Eckstein, F.S.; Ziemer, G. // Perfusion;1999, Vol. 14 Issue 1, p21 

    Extracorporeal circulation (ECC) in paediatric patients with heparin-coated oxygenation systems is rarely investigated. The objective of this study was to evaluate, preclinically, the haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces. We compared 16 paediatric...

  • Heparin.  // Reactions Weekly;11/17/2012, Issue 1428, p20 

    The article describes the case of a 59-year-old man who developed heparin resistance after receiving heparin for open heart surgery for the treatment of acute anterior myocardial infarction (MI).

  • Heparin monitoring during cardiac surgery. Part 2: calculating the overestimation of heparin by the activated clotting time. Raymond, P.D.; Ray, M.J.; Callen, S.N.; Marsh, N.A. // Perfusion;Sep2003, Vol. 18 Issue 5, p277 

    Activated clotting time (ACT) values were converted to heparin concentration, enabling an assessment of the accuracy of the ACT and a quantification of the prolongation imposed by bypass. Blood samples were obtained from 42 adult cardiopulmonary bypass (CPB) patients before and during bypass...

  • Heparin monitoring during cardiac surgery. Part 1: validation of whole-blood heparin concentration and activated clotting time. Raymond, P.D.; Ray, M.J.; Callen, S.N.; Marsh, N.A. // Perfusion;Sep2003, Vol. 18 Issue 5, p269 

    There is limited published data on the agreement between techniques for monitoring heparin levels. The aim of this study was to validate the Hepcon/HMS, with particular focus on the agreement with laboratory anti-Xa assay. The performances of two ACT instruments - Hemochron and HemoTec - were...

  • Danaparoid-sodium/heparin.  // Reactions Weekly;1/21/2017, Vol. 1635 Issue 1, p105 

    An abstract of the article "Cross-Reactivity Between Heparin and Danaparoid Antibodies in Cardiac Surgery" by T. Ronchard and others is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics